DoW Ovarian Cancer, Clinical Trial Award
About the Opportunity
The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.
Funding Instrument Type: Grant
Expected Number of Awards: 2
Estimated Total Program Funding: $5,600,000
Posted Date: May 04, 2026
Current Closing Date for Applications: October 01, 2026
Eligibility
Eligible Applicants: Unrestricted (i.e., open to any type of entity).
Assistance Listings: 12.420 -- Military Medical Research and Development
Description
The OCRP Clinical Trial Award focuses on clinical trials designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies for ovarian cancer.
- Projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate feasibility or inform the design of more advanced trials.
- Large-scale trials to determine efficacy in relevant patient populations are also supported.
Contact Information
For assistance, contact the eBRAP Help Desk:
- Phone: 301-682-5507
- Email: help@ebrap.org